Skip to content

Author

Hero Hamad

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Targeted mutational profiling of Fms-like tyrosine kinase 3, nucleophosmin 1, and isocitrate dehydrogenase 2 in acute myeloid leukemia: Associations with remission, subtypes, and survival

Clinical significance of FLT3, NPM1, and IDH2 mutations in AML is supported and the potential role of these genes in targeted therapy considerations is highlighted.

Hero Hamad, G. Othman, R. Polus · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.